Transcranial magnetic stimulation for altering susceptibility of tissue to pharmaceuticals and radiation
US9492679B2 · kind B2 · utility
5Cited by
64References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2011 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Aug 18, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2/02
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Described herein are methods for modulating the susceptibility of one or more target or tissue regions, and particularly one or more brain regions, to a therapeutic agent such as a drug, immune agent, compound, radiation, etc. In particular, the methods and systems described herein may include magnetic stimulation (including transcranial magnetic stimulation) of target or non-target regions to modulate the susceptibility of the one or more target or tissue regions to a therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.